Search Within

Linda Hamadene

Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Department of Medicine (6)
  2. GSK Faculty (6)
  3. Melanoma and Immunotherapeutics Service (6)
  4. Sloan Kettering Institute Postdocs (6)
  5. Solid Tumor Oncology Division (6)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Jedd Wolchok (6)
  2. Taha Merghoub (6)
  3. Allison Betof Warner (4)
  4. Daniel Hirschhorn Cymerman (4)
  5. Levi Mark Mangarin (4)
  6. Alan Houghton (3)

More People

Years
  1. 2022 (4)
  2. 2021 (2)
Publications
  1. Cancer Research (3)
  2. Journal for ImmunoTherapy of Cancer (2)
  3. JCI Insight (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Biomed Central Ltd (2)
  3. Amer Soc Clinical Investigation Inc (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Signal-regulatory protein alpha (SIRPĪ±) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Potential role of CD47 in T cell exhaustion program
    Meeting Abstract

    Weng, C. H.; Samaan, F.; Budhu, S.; Mangarin, L.; Monette, S.; Liu, C.; Pourpe, S.; Hamadene, L.; Zhong, H.; Yang, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
    Meeting Abstract

    George, M. M.; Warner, A. B.; Hamadene, L.; Hirschhorn, D.; Houghton, A. N.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
    Journal Article

    Hirschhorn, D.; Betof Warner, A.; Maniyar, R.; Chow, A.; Mangarin, L. M. B.; Cohen, A. D.; Hamadene, L.; Rizzuto, G. A.; Budhu, S.; Suek, N.; more...
    JCI Insight (2021)

    Fulltext@MSK | Save
  • Combination of cyclophosphamide chemotherapy with immune modulation overcomes resistance to checkpoint blockade in a pre-clinical melanoma model
    Meeting Abstract

    Betof Warner, A.; Hirschhorn, D.; Mangarin, L. M.; Hamadene, L.; Cohen, A. D.; Rizzuto, G. A.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2021)

    Fulltext@MSK | Save